Shares of Dhampur Bio Organics Ltd. dropped 2.98%, trading at ₹130.16 on the NSE as of 9:24 am, following the release of its Q2 FY2025 financial results. The company reported a net loss of ₹23.37 crore for the quarter ended September 2024, contrasting with a marginal net profit of ₹0.06 crore in the same period last year.
Q2 Financial Highlights:
- Sales: Declined 13.42% YoY to ₹465.97 crore, down from ₹538.18 crore in Q2 FY2024.
- Operating Profit Margin (OPM): Turned negative at -2.09%, compared to 3.56% in the same quarter last year.
- Profit Before Depreciation and Tax (PBDT): Reported a loss of ₹24.12 crore, compared to ₹10.97 crore profit in Q2 FY2024.
- Profit Before Tax (PBT): Loss of ₹35.44 crore, down from ₹0.48 crore in the previous year.
This financial performance reflects a challenging quarter for Dhampur Bio, impacted by declining sales and a shift from profit to loss across several profitability metrics.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.